# Exercise and Intranasal Insulin in Type 2 Diabetes

> **NCT07675499** · PHASE2,PHASE3 · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes
- Insulin Sensitivity/Resistance
- Cognition
- Brain Blood Flow

## Interventions

- **DRUG:** Intranasal Insulin
- **DRUG:** Intranasal Placebo
- **BEHAVIORAL:** High Intensity Exercise

## Key facts

- **NCT ID:** NCT07675499
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2029-05-18
- **Final completion:** 2029-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675499, "Exercise and Intranasal Insulin in Type 2 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*